Global Clinical Nutrition For Cancer Care Report 2024-2030, by Product (Oral, Nutrition Enteral Feeding Formulas, Parenteral Nutrition), Stage, Sales Channel, Region and Segment Forecasts

Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Nutrition For Cancer Care Market Size, Share & Trends Analysis Report by Product (Oral, Nutrition Enteral Feeding Formulas, Parenteral Nutrition), Stage, Sales Channel, Region, and Segment Forecasts, 2024-2030" report has been added to * ResearchAndMarkets.com's* offering.

The global clinical nutrition for cancer care market size is estimated to reach USD 7.95 billion by 2030, growing at a CAGR of 5.04% during the forecast period. Advancements in medical foods for cancer care have been a significant area of focus in research and development, aiming to enhance treatment outcomes and boost the overall quality of life for individuals battling cancer.

The growing statistics of patients with cancer underscore the increasing need for comprehensive strategies to address the nutritional burden and provide support for affected populations worldwide. Furthermore, weakened immunity due to cancer affects the response to the treatment as well as increases treatment-related toxicity. Hence, to maintain nutrition and positive nitrogen balance, various type of clinical nutrition such as tube feeding is used.

Many market players intend to tackle the byproducts of oncological treatment, namely malnutrition, cachexia, and diminished physical function, using effective nutritional strategies. Addressing these nutritional issues involves personalized interventions by healthcare providers, including nutritional counseling, dietary modifications, and potentially oral nutritional supplements.

Technological advancements in allied industries, such as enteral feeding devices, positively impact market growth. Key players are launching products that can be administered through the enteral route, propelling the market growth. Furthermore, government support in the form of approvals is anticipated to fuel the market growth over the forecast period.

*Clinical Nutrition for Cancer Care Market Report Highlights*

· The significance of clinical nutrition for cancer patient care assures upwards growth for the market as it improves quality of life and treatment outcomes. With the growing emphasis on personalized treatments for various illnesses, including cancer and cystic fibrosis, the application of clinical nutrition has gained momentum.
· The U.S. dominated the North America market with over 87% market revenue share, owing to its emphasis on research and substantial investment in the development of nutritional alternatives.
· To cater to diverse nutritional needs, there has been a significant rise in the introduction of new oncology nutrition products, specifically designed to aid patients in combating diseases and managing the after-effects of treatment.
· Oral nutrition led the product segment in 2023 with over 44% market share; however, parenteral feeding formulas are anticipated to register lucrative growth in the future.
· Market growth is dominant for adult patients with cancer consuming medical foods. Moreover, the adults segment is expected to register the fastest CAGR from 2024 to 2030. This is attributable to the widespread occurrence of malnutrition in adult patients with cancer.
· To cater to their nutritional needs, there has been a significant rise in the introduction of new oncology nutrition products, specifically designed to aid patients in combating diseases and managing the after-effects of treatment.
· Clinical nutrition for cancer care market in Europe was the second-largest regional market in 2023, and Germany is estimated to dominate the market in the region over the forecast period.
· To strengthen their positions in the clinical nutrition sector focused on cancer care, companies have undertaken strategic mergers and acquisitions to enrich their portfolios and boost market reach.

*Key Attributes:*
*Report Attribute* *Details*
No. of Pages 125
Forecast Period 2023 - 2030
Estimated Market Value (USD) in 2023 $5.63 Billion
Forecasted Market Value (USD) by 2030 $7.95 Billion
Compound Annual Growth Rate 5.0%
Regions Covered Global
*Key Topics Covered:*

*Chapter 1. Methodology and Scope*

*Chapter 2. Executive Summary*
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

*Chapter 3. Clinical Nutrition for Cancer Care Market Variables, Trends & Scope*
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.3. Global Clinical Nutrition for Cancer Care Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.2. PESTEL Analysis

*Chapter 4. Clinical Nutrition for Cancer Care Market: Product Estimates & Trend Analysis*
4.1. Global Clinical Nutrition for Cancer Care Market: Product Dashboard
4.2. Global Clinical Nutrition for Cancer Care Market: Product Movement Analysis
4.3. Global Clinical Nutrition for Cancer Care Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.4. Oral Nutrition
4.5. Parenteral Nutrition
4.6. Enteral Feeding Formulas

*Chapter 5. Clinical Nutrition for Cancer Care Market: Stage Estimates & Trend Analysis*
5.1. Clinical Nutrition for Cancer Care Market: Stage Dashboard
5.2. Clinical Nutrition for Cancer Care Market: Stage Movement Analysis
5.3. Clinical Nutrition for Cancer Care Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.4. Adult
5.5. Pediatric

*Chapter 6. Clinical Nutrition for Cancer Care Market: Sales Channel Estimates & Trend Analysis*
6.1. Global Clinical Nutrition for Cancer Care Market: Sales Channel Dashboard
6.2. Global Clinical Nutrition for Cancer Care Market: Sales Channel Movement Analysis
6.3. Global Clinical Nutrition for Cancer Care Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.4. Online
6.5. Retail
6.6. Institutional Sales

*Chapter 7. Clinical Nutrition for Cancer Care Market: Regional Estimates & Trend Analysis*
7.1. Regional Market Share Analysis, 2023 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:

*Chapter 8. Competitive Landscape*
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Vendor Landscape

· Abbott Nutrition
· Pfizer
· Bayer
· Nestle Health Science
· GlaxoSmithKline
· Baxter International
· Otsuka Holdings
· Mead Johnson & Company
· Danone Nutricia
· Victus

For more information about this report visit https://www.researchandmarkets.com/r/6ofvqh

*About ResearchAndMarkets.com*
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

*Attachment*

· Global Clinical Nutrition For Cancer Care Market

CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900